SCHEMBL12011506

SCHEMBL12011506

c1ccc(Sc2ccc3c(c2)c2ccccc2c2cc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c4ccccc4c32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ GPR84 Q9NQS5 1/20 0.33
▸ SOS1 Q07889 2/20 0.32
▸ GSTP1 P09211 1/20 0.32
▸ MAP2K2 P36507 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MAOA P21397 1/20 0.31
▸ MAOB P27338 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ PIM1 P11309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12011503 0.79 GSTP1 (0.37) GPR84SOS1GSTP1MAOAMAOB
SCHEMBL12011504 0.78 CYP11B2 (0.46) LMNAKDM4EMAPTKMT2ANPSR1
SCHEMBL12011510 0.76 HSD17B1 (0.35) KMT2AGPR84SOS1GSTP1CYP1A2
SCHEMBL12011508 0.75 SMN1; SMN2 (0.41) LMNAKDM4EMAPTPKMKMT2A
SCHEMBL12011507 0.75 TUBB4A (0.34) KDM4EGPR84GSTP1HDAC4HDAC2
SCHEMBL12011505 0.74 KDM4E (0.40) KDM4EKMT2AGPR84SOS1
SCHEMBL12011498 0.74 IKBKB (0.34) KDM4EKMT2AGPR84GSTP1SMN1; SMN2
SCHEMBL12011499 0.74 IKBKB (0.34) KDM4EKMT2AGPR84GSTP1SMN1; SMN2
SCHEMBL12011509 0.73 KDM4E (0.35) KDM4EGSTP1HDAC4
SCHEMBL20374971 0.73 LIMK1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8253129-B2 Benzochrysene derivative and an organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-08-28 — — US disclosed
US-8253129-B2 Benzochrysene derivative and an organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-08-28 — — US disclosed
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-11-25 — — US disclosed
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-11-25 — — US disclosed
EP-2213640-A1 BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2010-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME KSR1, NRAS, RSU1 LMNA 3864/4885KDM4E 2471/4885MAPT 4186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback